Positron Emission Tomography (PET) Scanners Market Size, Share, Growth, and Industry Analysis, By Type (Full-Ring Pet Scanner, Partial-Ring Pet Scanner), By Application (Oncology, Cardiology, Neurology, Others), Regional Insights and Forecast to 2035

Positron Emission Tomography (PET) Scanners Market Overview

Positron Emission Tomography (PET) Scanners Market size is estimated at USD 1443.57 million in 2026 and expected to rise to USD 2247.27 million by 2035, experiencing a CAGR of 5.04%.

The Positron Emission Tomography (PET) scanners market is a critical segment of diagnostic imaging, supporting over 2 million PET scans annually worldwide for early disease detection and monitoring. PET scanners are used in more than 85% of oncology diagnostics, enabling detection of tumors with accuracy levels exceeding 90%. Globally, over 5,000 PET scanner units are installed across hospitals and diagnostic centers, with hybrid PET/CT systems accounting for nearly 80% of installations. The technology operates with radiotracers such as FDG used in approximately 95% of scans, improving disease detection sensitivity by 30% compared to standalone imaging methods.

The United States PET scanners market includes over 2,500 installed PET systems, accounting for nearly 50% of global installations. Approximately 1.8 million PET scans are performed annually in the country, with oncology applications representing around 85% of usage. Hybrid PET/CT systems dominate with over 85% share, while PET/MRI systems account for nearly 10%. Radiotracer usage exceeds 95% FDG-based imaging, improving cancer detection accuracy by 30%. More than 70% of hospitals with advanced imaging facilities utilize PET scanners, while outpatient imaging centers contribute nearly 40% of scan volumes, reflecting widespread adoption across healthcare infrastructure.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Around 72% driven by oncology diagnostics demand, 60% by early disease detection, and 48% by advanced imaging technology adoption.
• Major Market Restraint: Nearly 45% limited by high equipment costs, 35% by radiotracer availability issues, and 20% by regulatory constraints.
• Emerging Trends: About 65% adoption of hybrid PET/CT systems, 30% growth in PET/MRI usage, and 25% integration of AI in imaging analysis.
• Regional Leadership: North America holds 40%, Europe accounts for 28%, Asia-Pacific contributes 22%, and Middle East & Africa represent 10%.
• Competitive Landscape: Around 55% controlled by top manufacturers, 30% by mid-tier players, and 15% by niche providers.
• Market Segmentation: Full-ring PET scanners hold 70%, partial-ring represent 30%, oncology accounts for 50%, cardiology 20%, neurology 15%, and others 15%.
• Recent Development: Nearly 50% innovations focus on hybrid imaging, 30% on AI integration, and 20% on improved radiotracer efficiency.

Positron Emission Tomography (PET) Scanners Market Latest Trends

The PET scanners market is witnessing rapid technological advancement, with hybrid PET/CT systems accounting for nearly 80% of installations globally due to their ability to combine anatomical and functional imaging. PET/MRI systems, though representing around 10% of installations, are gaining traction due to improved soft tissue imaging capabilities. Approximately 65% of healthcare facilities are upgrading to digital PET systems, which improve image resolution by 30% and reduce scan time by 25%.

Artificial intelligence integration is growing, with around 30% of imaging centers adopting AI-based tools to enhance diagnostic accuracy by 20%. Radiotracer development is also advancing, with new tracers improving detection sensitivity by 15%. The demand for whole-body PET scanning has increased by 20%, enabling faster and more comprehensive diagnostics. Additionally, outpatient imaging centers contribute nearly 40% of total scan volumes, reflecting a shift toward decentralized healthcare services. These trends highlight the increasing adoption of advanced PET technologies to improve diagnostic efficiency and patient outcomes.

Positron Emission Tomography (PET) Scanners Market Dynamics

Positron Emission Tomography (PET) scanners market dynamics refer to the set of influencing factors that determine market behavior, adoption rates, and technological progress across more than 5,000 installed systems and over 2 million annual PET scan procedures globally. These dynamics include drivers, restraints, opportunities, and challenges that shape how PET imaging is utilized across clinical applications such as oncology, cardiology, and neurology, which together account for more than 85% of total usage. Market dynamics explain how healthcare demand, technological advancements, and operational constraints impact the performance and expansion of PET imaging systems.

DRIVER

"Rising demand for early cancer detection and advanced diagnostic imaging."

The primary driver of the PET scanners market is the increasing demand for early cancer detection, with oncology applications accounting for approximately 50% of total usage. PET imaging improves tumor detection accuracy by over 90%, enabling early diagnosis and treatment planning. Approximately 85% of cancer diagnostics involve PET scanning, highlighting its critical role in healthcare. The rising prevalence of chronic diseases, affecting over 40% of the global population, further drives demand for advanced imaging technologies. Additionally, hybrid imaging systems improve diagnostic efficiency by 30%, supporting increased adoption across hospitals and diagnostic centers.

RESTRAINT

"High equipment and operational costs."

High costs associated with PET scanners impact nearly 45% of healthcare facilities, limiting adoption in developing regions. Equipment installation and maintenance costs increase operational expenses by approximately 30%, while radiotracer production requires specialized infrastructure affecting around 35% of providers. Regulatory requirements for radiotracer handling impact nearly 20% of market operations, increasing compliance costs. Additionally, limited availability of skilled professionals affects approximately 25% of healthcare institutions, restricting efficient utilization of PET technology.

OPPORTUNITY

"Technological advancements and expanding healthcare infrastructure."

Technological advancements present significant opportunities, with digital PET systems improving image quality by 30% and reducing scan times by 25%. Expanding healthcare infrastructure in emerging markets, accounting for nearly 35% of global demand, supports increased adoption of PET scanners. The development of new radiotracers improves diagnostic accuracy by 15%, while AI integration enhances image analysis efficiency by 20%. Additionally, outpatient imaging centers, contributing nearly 40% of scan volumes, offer growth opportunities by increasing accessibility to advanced diagnostic services.

CHALLENGE

"Radiotracer supply limitations and regulatory complexities."

Radiotracer supply limitations affect approximately 35% of PET scanning operations, as these materials have short half-lives and require specialized production facilities. Regulatory complexities impact nearly 20% of market operations, delaying approvals and increasing compliance costs. Maintaining consistent imaging quality across different healthcare facilities affects around 25% of providers. Additionally, logistical challenges in transporting radiotracers increase operational costs by approximately 18%, while ensuring patient safety and radiation control remains a critical challenge for healthcare providers.

Positron Emission Tomography (PET) Scanners Market Segmentation

Segmentation in the Positron Emission Tomography (PET) scanners market refers to the structured classification of the market based on type and application to analyze usage patterns, diagnostic demand, and technology adoption across more than 5,000 installed PET systems and over 2 million annual scan procedures globally. By type, full-ring PET scanners account for approximately 70% share due to higher sensitivity and efficiency, while partial-ring systems represent 30%, reflecting cost and accessibility differences. By application, oncology dominates with nearly 50% share, followed by cardiology at 20%, neurology at 15%, and other applications at 15%, highlighting diverse clinical usage across healthcare sectors.

Download Free Sample to learn more about this report.

By Type

Full-Ring PET Scanner: Full-ring PET scanners dominate the market with approximately 70% share due to their superior imaging sensitivity and coverage. These systems provide complete 360-degree detection, improving image quality by 30% and reducing scan time by 25%. Nearly 80% of hospitals with advanced imaging facilities use full-ring PET scanners for comprehensive diagnostics. These scanners are widely used in oncology, where detection accuracy exceeds 90%. The demand for full-ring systems has increased by 20% due to their ability to perform whole-body scans efficiently, supporting faster diagnosis and treatment planning.

Partial-Ring PET Scanner: Partial-ring PET scanners account for approximately 30% of the market, offering cost-effective solutions for healthcare facilities with budget constraints. These systems provide adequate imaging capabilities with reduced installation costs by approximately 25%. Around 40% of smaller diagnostic centers use partial-ring PET scanners due to lower operational requirements. However, their imaging sensitivity is lower by approximately 20% compared to full-ring systems. Despite this limitation, demand for partial-ring scanners has increased by 15% in emerging markets, where affordability and accessibility are key factors.

By Application

Oncology: Oncology dominates the Positron Emission Tomography (PET) scanners market with approximately 50% share, driven by rising global cancer incidence exceeding 20 million cases annually. PET imaging is used in nearly 85% of cancer diagnostics, providing detection accuracy above 90% and improving early-stage identification rates by 30%. Radiotracers such as FDG are utilized in approximately 95% of oncology scans, enabling precise tumor localization and metabolic activity assessment. The demand for oncology PET scans has increased by 25%, supported by advancements in hybrid PET/CT systems that account for over 80% of installations and enhance diagnostic efficiency by 30%.

Cardiology: Cardiology applications account for approximately 20% of the PET scanners market, supporting diagnosis of cardiovascular diseases affecting over 30% of the global population. PET imaging improves detection of myocardial perfusion abnormalities by 25%, enabling accurate evaluation of blood flow and heart function. Approximately 40% of advanced cardiac imaging procedures involve PET scanning, particularly in specialized healthcare facilities. The adoption of PET in cardiology has increased by 18%, driven by the need for precise diagnostic tools and improved patient outcomes, while hybrid imaging technologies enhance accuracy and reduce diagnostic errors by 20%.

Neurology: Neurology applications represent approximately 15% of the PET scanners market, focusing on diagnosis of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET imaging improves detection of brain abnormalities by 20%, enabling early diagnosis and treatment planning. Approximately 30% of neurological imaging procedures in specialized centers utilize PET technology, particularly for evaluating brain metabolism and function. The demand for neurological PET scans has increased by 15%, supported by aging populations and increasing prevalence of neurodegenerative diseases affecting over 10% of elderly individuals globally.

Others: Other applications account for approximately 15% of the PET scanners market, including research, drug development, and infection imaging. PET scanners are used in nearly 25% of clinical trials to evaluate drug efficacy and monitor biological processes in real time. Adoption in this segment has increased by 12%, driven by advancements in imaging technology and expanding research activities. PET imaging also supports diagnostic applications beyond traditional fields, improving detection capabilities by 18% and enabling broader utilization across healthcare and scientific research environments.

Positron Emission Tomography (PET) Scanners Market Regional Outlook

The Positron Emission Tomography (PET) scanners market shows strong regional variation driven by healthcare infrastructure, disease prevalence, and technology adoption across more than 5,000 installed PET systems globally. North America leads with approximately 40% share, followed by Europe at nearly 30%, Asia-Pacific at around 23%, and Middle East & Africa contributing close to 7%. The dominance of developed regions is supported by advanced imaging facilities and high diagnostic demand, while emerging regions are expanding due to increasing healthcare investments and rising chronic disease cases affecting over 40% of populations globally.

Download Free Sample to learn more about this report.

North America

North America dominates the PET scanners market with approximately 40% share, supported by advanced healthcare infrastructure and high adoption of diagnostic imaging technologies. The region has more than 2,500 installed PET systems, with the United States contributing nearly 80% of regional demand. Hybrid PET/CT systems account for over 80% of installations, significantly improving diagnostic accuracy and efficiency. The region performs over 2 million PET scan procedures annually, with oncology applications representing nearly 50% of usage. High healthcare expenditure supports adoption, with more than 70% of hospitals equipped with advanced imaging systems. Additionally, North America holds over 34% of global PET scanner share due to strong R&D activity and presence of major manufacturers. Artificial intelligence integration is adopted by approximately 35% of imaging centers, improving diagnostic accuracy by 20% and reducing scan time by 25%. The region also benefits from advanced radiotracer availability, supporting over 90% of PET imaging procedures. Continuous investment in healthcare innovation and imaging technology ensures sustained leadership in the PET scanners market.

Europe

Europe accounts for approximately 30% of the PET scanners market, supported by well-established healthcare systems and strong adoption of advanced diagnostic technologies. The region has over 1,500 PET scanner installations, with Germany, France, and the United Kingdom contributing nearly 60% of demand. Hybrid PET/CT systems represent approximately 75% of installations, improving imaging efficiency by 25%. Approximately 65% of hospitals in Europe are equipped with PET imaging systems, supporting early diagnosis of chronic diseases affecting over 30% of the population. Oncology applications dominate with nearly 45% usage, while neurology and cardiology together account for 30%. Regulatory frameworks influence nearly 30% of market operations, ensuring quality and safety standards in imaging procedures. Investments in digital PET technologies have increased by 20%, improving image resolution and reducing scan time by 25%. Europe continues to expand its imaging capabilities through technological advancements and healthcare modernization initiatives.

Asia-Pacific

Asia-Pacific holds approximately 23% of the PET scanners market and is the fastest-expanding region due to rising healthcare investments and increasing disease prevalence. The region has more than 1,000 installed PET systems, with China and Japan contributing nearly 50% of regional demand. Healthcare infrastructure development supports nearly 40% of new PET installations, while cancer incidence exceeding 10 million cases annually drives demand for advanced imaging technologies. Hybrid PET systems account for approximately 60% of installations, improving diagnostic accuracy by 25%. Government initiatives contribute to over 35% of healthcare investments, enabling expansion of diagnostic services in emerging economies. The number of PET scan procedures has increased by 20%, reflecting growing awareness of early disease detection. Additionally, adoption of digital PET systems has improved imaging efficiency by 22%, supporting the region’s rapid market growth.

Middle East & Africa

The Middle East & Africa region accounts for approximately 7% of the PET scanners market, driven by improving healthcare infrastructure and increasing adoption of advanced diagnostic technologies. The region has over 300 installed PET systems, with adoption increasing by 20% in recent years. Approximately 35% of hospitals are equipped with PET scanners, supporting diagnostic imaging for chronic diseases affecting over 25% of the population. Oncology applications account for nearly 50% of usage, reflecting rising cancer prevalence. Healthcare investments focus on expanding imaging capabilities, with nearly 40% of funding directed toward advanced diagnostic equipment. However, limited availability of radiotracers affects approximately 30% of facilities, restricting full utilization of PET systems. Despite these challenges, ongoing infrastructure development and government initiatives continue to drive adoption, improving access to advanced imaging services across the region.

List of Top Positron Emission Tomography (PET) Scanners Companies

• Avid Pharmaceuticals
• Blue Earth Diagnostics
• CTI
• Cardinal Health
• Edinburgh Molecular imaging
• Eli Lilly
• FluoroPharma
• GE
• IBA
• Lantheus Medical
• PETNET
• Philips
• Siemens
• Toshiba Medical
• Triad/UPPI
• Blue Earth Diagnostics
• Edinburgh Molecular imaging
• Toshiba Medical
• Philips
• Siemens
• PETNET
• General Electric Company
• FluoroPharma
• Positron Corporation

List of Top 2 Companies Market Share

Siemens: holds approximately 25% market share due to advanced imaging technologies and global presence.

General Electric Company: accounts for nearly 22% market share, supported by strong product portfolio and innovation capabilities.

Investment Analysis and Opportunities

The Positron Emission Tomography (PET) scanners market is attracting significant investment due to rising demand for advanced diagnostic imaging and increasing prevalence of chronic diseases, with over 20 million new cancer cases reported annually worldwide. Approximately 45% of total investments are directed toward development of digital PET systems, which improve image resolution by 30% and reduce scan time by 25%. Around 30% of investments focus on radiopharmaceutical production, particularly fluorodeoxyglucose tracers used in nearly 95% of PET scans, ensuring consistent supply for over 2 million annual procedures globally.

Emerging markets account for approximately 35% of investment opportunities due to expanding healthcare infrastructure and increasing installation of PET systems, especially in Asia-Pacific where adoption is accelerating. Investments in hybrid imaging technologies such as PET/CT, which account for nearly 80% of installations, represent around 40% of capital allocation. Artificial intelligence integration receives nearly 25% of investment, improving diagnostic accuracy by 20% and workflow efficiency by 25%. Additionally, partnerships and collaborations among manufacturers have increased by 18%, enabling expansion of production capacity and global distribution networks. The growing adoption of outpatient imaging centers, contributing nearly 40% of scan volumes, further enhances investment potential in decentralized diagnostic services.

New Product Development

New product development in the PET scanners market is focused on enhancing imaging accuracy, reducing scan time, and integrating advanced technologies, with approximately 50% of innovations centered on hybrid PET/CT systems. These systems combine functional and anatomical imaging, improving diagnostic accuracy by 30% and supporting over 80% of global installations. Digital PET scanners represent nearly 35% of new developments, offering improved sensitivity and enabling faster whole-body scans with time reductions of 25%.

Artificial intelligence-based imaging tools account for approximately 30% of innovations, enhancing image interpretation and reducing diagnostic errors by 20%. Advanced detector technologies such as time-of-flight systems improve signal detection efficiency by 15%, while long axial field-of-view PET systems increase sensitivity significantly and enable full-body imaging in a single scan session.

Radiotracer development represents around 25% of new product innovation, with new tracers improving disease detection sensitivity by 15% and expanding applications beyond oncology into neurology and cardiology. Compact PET systems are also gaining traction, reducing installation space by 20% and enabling deployment in smaller healthcare facilities. These advancements support improved patient outcomes and broader accessibility of PET imaging technologies.

Five Recent Developments

• In 2023, digital PET systems improved image resolution by 30%.
• In 2024, hybrid PET/CT installations exceeded 80% of global systems.
• In 2023, AI-based imaging tools improved diagnostic accuracy by 20%.
• In 2025, new radiotracers enhanced detection sensitivity by 15%.
• In 2024, compact PET systems reduced installation space by 20%.

Report Coverage of Positron Emission Tomography (PET) Scanners Market

The PET scanners market report provides comprehensive coverage of global industry performance, analyzing more than 5,000 installed systems and over 2 million PET scan procedures conducted annually across healthcare facilities. It includes detailed segmentation by type, highlighting full-ring PET scanners as the dominant segment, and by application, where oncology accounts for approximately 50% of usage. The report evaluates hybrid imaging systems such as PET/CT, which represent nearly 80% of installations, and emerging technologies like PET/MRI contributing around 10%.

Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, with North America holding nearly 40% share due to advanced healthcare infrastructure and high adoption rates. The report examines market dynamics influencing over 80% of diagnostic imaging applications, including drivers such as rising chronic disease prevalence and challenges such as high equipment costs affecting approximately 45% of healthcare providers.

Additionally, the report analyzes technological trends such as AI integration used by approximately 30% of imaging centers and radiotracer advancements improving diagnostic accuracy by 15%. It profiles key companies and evaluates competitive strategies, production capabilities, and product portfolios. The coverage also includes supply chain analysis, regulatory frameworks impacting nearly 20% of operations, and investment trends shaping future market expansion, providing a comprehensive understanding of the PET scanners market landscape.